Navigation Links
Advances in Cosmesis Increase Amputee Acceptance of Prosthesis and Orthotics Devices, Finds Frost & Sullivan
Date:12/12/2012

MOUNTAIN VIEW, Calif., Dec. 12, 2012 /PRNewswire/ -- The orthotics and prosthetics (O&P) industry is becoming a fertile ground for innovation because of the expanding patient pool of the elderly and disabled as well as numerous technological breakthroughs. The improving quality of O&P devices and services due to regular clinical interventions and integration of the interpreted data into patient care have considerably enhanced their uptake.

New analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com) Advances in Bionic Prosthesis and Orthotics finds that the O&P industry is experiencing a blend of multiple streams of science and technology. Consequently, market participants must strategize to align competencies, capabilities and resources to expand their market share.

If you are interested in more information on this research, please email Britni Myers, Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"Advances in plastic fabrication, structures and materials help manufacturers produce better artificial limbs at a much quicker pace," said Technical Insights Research Analyst Saju John Mathew. "Further, the advent of microprocessors has transformed the overall prosthetics landscape."

Currently, many versions of prosthesis can be developed to fit a patient's varying motor skills, facilitating better functionality and integration with the patient's needs. Superior cosmesis enables the matching of the prosthetics with the patient's sound side to camouflage any disability.

However, there is always a risk of microbial infection during surgical insertion of a prosthetic in the body and this discourages its use. The Food and Drug Administration (FDA) can also peg back the newly conceived technology/product by delaying its commercial launch. In some instances, technology developers prefer to conduct their R&D overseas, citing regulatory delays.

O&P devices, specifically related to neurostimulation technologies, are still at an early stage of commercialization. Developers need to ensure smoother regulatory approvals to attract investors and partners, and to gain global market shares.

As the technology gets smarter and new materials and structures are invented, biocompatibility issues will be resolved. Miniaturization will further enhance the appeal of O&P devices among patients and boost the technology's adoption.

"A strong R&D network under one umbrella can help developers complement existing technologies and explore other applications," noted Mathew. "Additionally, a hassle-free R&D environment aids uninterrupted funding and technology transfer between partners to enhance the value of the developed technology/product."

Advances in Bionic Prosthesis and Orthotics, part of the Technical Insights subscription, outlines the R&D platform and the necessary factors required for the growth of the O&P industry. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Advances in Bionic Prosthesis and Orthotics    
D2F7-TI

Contact:    
Britni Myers    
Corporate Communications – North America    
P: 210.477.8481    
F: 210.348.1003    
E: britni.myers@frost.com    

http://www.frost.com
http://www.technicalinsights.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
2. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
3. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. URAC sets standards for community pharmacy, advances dialogue about pharmacists as medication experts
6. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
7. Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
8. Accelrys ELN Advances Innovation Lifecycle Management with Enhanced Biology Capabilities from Screening to Preclinical Development
9. Advances in Delivery to the Central Nervous System
10. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
11. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... DUBLIN , Dec 2, 2016 Research ... Pipeline Database" newsletter to their offering. ... , , ... La Merie Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online ... therapeutic drugs on the market and on investigational drug candidates in ...
(Date:12/2/2016)... the largest share in the ECG Cables And ECG Leadwires ... remote monitoring ECG devices. On the other hand, the ... the highest growth rate during the forecast period. ... Company (U.S.), Medtronic plc ( Ireland ), Koninklijke ... Medical International Limited ( China ), held major ...
(Date:12/2/2016)... Quantum Radiology,s Mobile Breast Center (QR MBC) brings cutting-edge ... at the workplace, thereby maximizing convenience and compliance.  QR ... and SunTrust Bank, and community health groups to provide ... "I think it,s a great service for ... a mammogram without taking a large amount of time ...
Breaking Medicine Technology:
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... The annual ... Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who ... C) or prescription drug plan (Part D) need to make changes during this period ...
(Date:12/2/2016)... Hills, CA (PRWEB) , ... December 02, 2016 ... ... reconstructive surgeon in Beverly Hills, California, will be included in the 2016 “Guide ... given to exceptional professionals based on the amalgamation of their education, experience, and ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering local frontline ... field of pain management. , The demand for supplemental training related to ...
(Date:12/2/2016)... Texas (PRWEB) , ... December 02, 2016 , ... Yisrayl ... that delves into how this current generation fits into Bible Prophecy. Yisrayl says this ... various facts pointing to this conclusion, showing how the details line up exactly with ...
Breaking Medicine News(10 mins):